|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||3.70 - 3.88|
|52 Week Range||0.61 - 7.77|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
VICTORIA, British Columbia, April 20, 2018-- Emerald Health Therapeutics Inc. today announced DDB Canada’ s Vancouver office its agency of record following a national search managed by Reynolds & Fyshe. ...
New joint venture, Emerald Health Naturals, secures exclusive Canadian rights to sell proprietary non-cannabis health products that support the human endocannabinoid system. Initiative leverages natural ...
VANC executes supply and distribution agreement with Emerald VANC issues warrants to Emerald VANCOUVER, British Columbia, April 17, 2018 (GLOBE NEWSWIRE) -- VANC Pharmaceuticals Inc. ( "VANC" ...
With major projects advancing, this burgeoning marijuana stock presents a mixed bag for investors.
VICTORIA, British Columbia, April 03, 2018-- Emerald Health Therapeutics Inc. has appointed Rebecca Wong as Vice President Quality Affairs, with responsibility for quality systems at Emerald’ s production ...
VICTORIA, British Columbia, April 02, 2018-- Emerald Health Therapeutics, Inc. has filed its audited financial statements and management discussion and analysis for the fiscal year ended December 31, 2017. ...
SEATTLE, March 07, 2018-- CFN Media Group, the leading creative agency and media network dedicated to legal cannabis, announces publication of an article examining recent developments with Emerald Health ...
Legal marijuana could be the first billion industry dominated by women. Yahoo Finance's Seana Smith, Andy Serwer and Jen Rogers discuss with BBG Ventures' Susan Lyne and Nisha Dua.